Medtech InsightSecuring medical device approvals from China’s National Medical Products Administration for new products or changes to existing products often takes longer than planned, leading to delays in product l
ScripThe EU Chamber of Commerce in China's (EUCCC) 2024 Business Confidence Survey shows that over 50% of respondents are considering cutting costs, and only 42% are expanding their investment in China - t
In VivoBiopharma Financing Biopharma financings during the third quarter of 2022 totaled $18.1bn from 236 deals. The largest was a $1.39bn royalty sale by Theravance Biopharma to Royalty Pharma , which acqu